| Name | N-(3,4-dimethyl-1,2-oxazol-5-yl)-2-[4-(1,3-oxazol-2-yl)phenyl]benzenesulfonamide |
|---|
| Description | BMS-193884 is a selective, orally active, and competitive ETA antagonist with 10000-fold greater affinity for the human ETA receptor (Ki=1.4 nM) than for the ETB receptor[1]. |
|---|---|
| Related Catalog | |
| Target |
ETA:1.4 nM (Ki) ETB:18700 nM (Ki) |
| References |
| Molecular Formula | C20H17N3O4S |
|---|---|
| Molecular Weight | 395.43200 |
| Exact Mass | 395.09400 |
| PSA | 106.61000 |
| LogP | 5.56800 |
|
~53%
176960-47-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 43, # 16 p. 3111 - 3117 |
|
~%
176960-47-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 43, # 16 p. 3111 - 3117 |
|
~%
176960-47-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 43, # 16 p. 3111 - 3117 |
|
~%
176960-47-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 43, # 16 p. 3111 - 3117 |